Cargando...
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information
Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence for its effectiveness has been established based on randomized clinical trials accounting for classical risk factors, such as hypertension, diabetes, and serum lipids. However, besides such classical risk f...
Guardado en:
| Publicado en: | J Atheroscler Thromb |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Japan Atherosclerosis Society
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147010/ https://ncbi.nlm.nih.gov/pubmed/33229815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.60087 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|